COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy
NCT: NCT05961332 · COMPLETED
Brief Summary
The goal of this clinical trial is to compare measurements of geographic atrophy (GA) area between several types of imaging, in order to assess accuracy. The main question to answer is which imaging device provides measurements that are most similar to the standard of care device. Participants will be patients of a retina doctor at University Station Eye Clinic with geographic atrophy, and can expect to be in the study for 60-75 minutes.
Frequently Asked Questions
What is COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy?
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy is a clinical trial registered under NCT05961332. Current status: COMPLETED.
What is the status of NCT05961332?
The current status of NCT05961332 (COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy) is: COMPLETED.
When did COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy start?
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy started on 2023-10-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.